Mekonos
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
44 Montgomery St Ste 300, San Francisco,...Phone Number
(408) 857-2014Website
www.mekonos.comRevenue
$7.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mekonos
Mekonos is a cell & gene technology company transforming synthetic biology and personalized medicine. Mekonos was founded in 2017 and is based in California, the United States.Explore more
Mekonos Org Chart
CN
Systems Integration Engineer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mekonos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Mekonos recently announced quarterly report
Check out if Mekonos is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Mekonos
Mekonos, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Mekonos launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Mekonos had a recent Job posting/layoffs
Check if Mekonos has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Mekonos has new funding data
Recommended Actions
Find VP level buyers at Mekonos
Find more new buyers
Compare Similar Companies to Mekonos
Compare insights from companies similar to Mekonos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mekonos is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mekonos is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mekonos.
Mekonos financials insights
Gather financial insights about Mekonos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$4.6M
2021
Series A
$25M
Mekonos Tech Stack
A closer look at the technologies used by Mekonos
Most Recent Scoops
Partnership
Product Development, Research & Development
Left Company
Mekonos has announced that Milad Alucozai, Chief Business Officer, has left the organization to join Entrepreneur First as Venture Partner.
Funding
Funding
Mekonos News & Media
Mekonos Appoints Benjamin Borgo as Chief Operating Officer
ALAMEDA, Calif.--(BUSINESS WIRE)--Mekonos, Inc., a biotech platform company building the future of cell therapies on a chip, today announced the appointment of Benjamin Borgo, MBA, PhD, as chief operating officer. In this newly created role, he will be responsible for developing and implementing operational strategies to support the growth and success of the business. Dr. Borgo reports to Anil Narasimha, PhD, co-founder, chief executive officer of Mekonos. “We are delighted to welcome Ben to thMekonos Announces Research Collaboration With bit.bio to Advance Cell Engineering
SAN FRANCISCO--(BUSINESS WIRE)--New collaboration combines Mekonos’ novel ex vivo delivery platform with bit.bio’s unique opti-ox™ precision cellular reprogramming technologyMekonos to Present at 2023 Cell & Gene Meeting on the Med
SAN FRANCISCO, April 6, 2023 /PRNewswire/ -- Mekonos announced today that Dr. Anil Narasimha, CEO & Co-Founder, will present at the annual Cell & Gene Meeting on the Med to be held April 12-14 in Barcelona, Spain and livestreamed globally. ex vivo nanoneedle-based delivery system enables...Opentrons' subsidiary Neochromosome and Mekonos announce new partnership to advance cell engineering for personalized medicine
SAN FRANCISCO, Dec. 14, 2021 /PRNewswire/ -- Mekonos, Inc., a biotech platform company building the future of cell therapies on a chip, has announced a new partnership with Neochromosome, Inc., a wholly-owned subsidiary of Opentrons Labworks focused on the creation of genome-scale cell...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Mekonos
Sign Up For FreeTo access detailed company insights
Mekonos is a cell & gene technology company transforming synthetic biology and personalized medicine. Mekonos was founded in 2017 and is based in California, the United States.... Read More
